Biosyntrx, Inc. Appoints New Board Member & New VP of Operations
January 12, 2012
Biosyntrx, Inc. CEO, Ellen Troyer, today announced that Akos Feher has been appointed to the Biosyntrx Board of Directors by the majority stockholders. Mr. Feher lives in Playa Del Rey, CA and holds degrees in engineering with an MBA from the University Of Southern California Marshall School Of Business. He has been a Biosyntrx strategic planning consultant for the past two years. Mr. Feher is an innovative, passionate and profit-driven professional with more than 12 years of experience in complex projects, brands and business infrastructure including consumer electronics, medical devices and dietary supplements.
Biosyntrx board and the majority stockholders also promoted David Amess from Business Development Director to Vice President of Operations. Mr. Amess has been with Biosyntrx for more than four years. He brings a Business Administration degree and almost 20 years of experience in banking, finance, and customer service management. David is Six Sigma certified, with a focus on statistical methods for problem solving and business model projections.
“Biosyntrx sales and revenue increased in 2011 despite today’s economy”, said Ellen Troyer. “We welcome 2012 with a revised business plan, an exciting pipeline, improved operations, an “on fire” board and executive management team with engaged and energized employees, consultants and distributors. Opportunities are knocking in the supplement industry and Biosyntrx maintains a global open door policy to legitimate opportunity.”
Spencer Thornton, MD, the Nashville TN based Biosyntrx President says, “Akos Feher and David Ames are passionate and exceptionally talented team players who will serve our stockholders and customers well in the new positions they hold.”
“The appointment of David Amess as Vice President for Operations with hi Six Sigma Certification is going to be a real plus in my opinion. Adding Akos Feher to the Board of Directors will give quality business judgment and experience.” said Jerre Freeman, MD.
About Biosyntx: Biosyntrx is an eye-care-specific privately held company incorporated in South Carolina with customer service offices and inside product sales located in downtown Columbia. The company’s executive offices including product research and development, web site development, operations, business development, marketing and education are located in Colorado Springs, Colorado. The primary Biosyntrx eye care-specific products are BioTears, a patented product that addresses the systemic nutrient needs of the dry eye patient. Macula Complete, a potent full-spectrum multiple designed for the diagnosed AMD, or those concerned about optimal full-body health and lack of energy; Oculair, a less potent full-body multiple and Avantrx, a meal-time portion-control product.
For additional information: contact Ellen Troyer at firstname.lastname@example.org or at 877-327-7889.